Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | -32.18% |
|
-15.75% | +136.13% |
Jun. 10 | Lipocine Inc. Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late-Breaking Session at EASL Congress 2024 | CI |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.